Spot on prowiz
"I find it quite interesting that breath right, CGP's rival product had $100m USD revenues in 2006, estimated $145m USD revenue in 2012. Acquired by GSK for $566m USD in 2007."
When this hits the world stage it won't be little ol' us peddling the turbine - this will get picked up next year and people will finally see the value of this little piece of plastic.
- Forums
- ASX - By Stock
- CGP
- outstanding potential!
outstanding potential!, page-4
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)